[Federal Register Volume 81, Number 45 (Tuesday, March 8, 2016)]
[Notices]
[Pages 12099-12102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05174]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2016-0062; FRL-9942-63]
FIFRA Scientific Advisory Panel; Notice of Public Meeting
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: There will be a 3-day meeting of the Federal Insecticide,
Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) to
consider and review Chlorpyrifos: Analysis of Biomonitoring Data.
DATES: The meeting will be held on April 19-21, 2016, from
approximately 9 a.m. to 5 p.m.
Comments. The Agency encourages written comments be submitted on or
before April 5, 2016, and requests for oral comments be submitted on or
before April 12, 2016. However, written comments and requests to make
oral comments may be submitted until the date of the meeting, but
anyone submitting written comments after April 5, 2016, should contact
the Designated Federal Official (DFO) listed under FOR FURTHER
INFORMATION CONTACT. For additional instructions, see Unit I.C. of the
SUPPLEMENTARY INFORMATION.
Nominations. Nominations of candidates to serve as ad hoc members
of FIFRA SAP for this meeting should be provided on or before March 23,
2016.
Webcast. This meeting may be webcast. Please refer to the FIFRA SAP
Web site at http://www.epa.gov/sap for information on how to access the
meeting webcast. Please note that the webcast is a supplementary public
process provided only for convenience. If difficulties arise resulting
in webcasting outages, the meeting will continue as planned.
Special accommodations. For information on access or services for
individuals with disabilities, and to request accommodation of a
disability, please contact the DFO listed under FOR FURTHER INFORMATION
CONTACT at least 10 days prior to the meeting to give EPA as much time
as possible to process your request.
ADDRESSES: Meeting: The meeting will be held at the Environmental
Protection Agency, Conference Center, Lobby Level, One Potomac Yard
(South Bldg.), 2777 S. Crystal Dr., Arlington, VA 22202.
Comments. Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2016-0062, by one of the following methods:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand-
delivery or delivery of boxed information, please
[[Page 12100]]
follow the instructions at http://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.
Nominations, requests to present oral comments, and requests for
special accommodations. Submit nominations to serve as ad hoc members
of FIFRA SAP, requests for special accommodations, or requests to
present oral comments to the DFO listed under FOR FURTHER INFORMATION
CONTACT.
FOR FURTHER INFORMATION CONTACT: Fred Jenkins, DFO, Office of Science
Coordination and Policy (7201M), Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington, DC 20460-0001; telephone number:
(202) 564-3327; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. This action may,
however, be of interest to persons who are or may be required to
conduct testing of chemical substances under the Federal Food, Drug,
and Cosmetic Act (FFDCA) and FIFRA. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities that may be affected by this action.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit CBI information to EPA through
regulations.gov or email. If your comments contain any information that
you consider to be CBI or otherwise protected, please contact the DFO
listed under FOR FURTHER INFORMATION CONTACT to obtain special
instructions before submitting your comments.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.
C. How may I participate in this meeting?
You may participate in this meeting by following the instructions
in this unit. To ensure proper receipt by EPA, it is imperative that
you identify docket ID number EPA-HQ-OPP-2016-0062 in the subject line
on the first page of your request.
1. Written comments. The Agency encourages written comments be
submitted, using the instructions in ADDRESSES and Unit I.B., on or
before April 5, 2016, to provide FIFRA SAP the time necessary to
consider and review the written comments. Written comments are accepted
until the date of the meeting, but anyone submitting written comments
after April 5, 2016, should contact the DFO listed under FOR FURTHER
INFORMATION CONTACT. Anyone submitting written comments at the meeting
should bring 30 copies for distribution to FIFRA SAP.
2. Oral comments. The Agency encourages each individual or group
wishing to make brief oral comments to FIFRA SAP submit their request
to the DFO listed under FOR FURTHER INFORMATION CONTACT on or before
April 12, 2016, to be included on the meeting agenda. Requests to
present oral comments will be accepted until the date of the meeting
and, to the extent that time permits, the Chair of FIFRA SAP may permit
the presentation of oral comments at the meeting by interested persons
who have not previously requested time. The request should identify the
name of the individual making the presentation, the organization (if
any) the individual will represent and any requirements for audiovisual
equipment. Oral comments before FIFRA SAP are limited to approximately
5 minutes unless prior arrangements have been made. In addition, each
speaker should bring 30 copies of his or her comments and presentation
for distribution to FIFRA SAP at the meeting.
3. Seating at the meeting. Seating at the meeting will be open and
on a first-come basis.
4. Request for nominations to serve as ad hoc members of FIFRA SAP
for this meeting. As part of a broader process for developing a pool of
candidates for each meeting, FIFRA SAP staff routinely solicits the
stakeholder community for nominations of prospective candidates for
service as ad hoc members of FIFRA SAP. Any interested person or
organization may nominate qualified individuals to be considered as
prospective candidates for a specific meeting. Individuals nominated
for this meeting should have expertise in one or more of the following
areas: Human biomonitoring data and interpretation of such data;
epidemiology (particularly reproductive/developmental, and
environmental), exposure assessment of pesticides (residential and
agricultural worker); route-specific pharmacokinetics (dermal, oral);
physiologically-based pharmacokinetic modeling (PBPK); cholinergic and
non-cholinergic mechanisms; cholinesterase inhibition; developmental
neurotoxicity; human health risk assessment; organophosphate
pesticides; and pharmacokinetics. [Note: In support of the U.S.
Environmental Protection Agency's (EPA) priority of ``Making a Visible
Difference in Communities'' across the country, the Agency is committed
to helping minority, low-income, tribal and other vulnerable
populations improve their health and environment. In an effort to
ensure that the Agency's proposed actions are taking into consideration
input from potential communities with environmental justice concerns,
the EPA is offering an opportunity to provide input on the FIFRA SAP
meeting to address scientific issues associated with ``Chlorpyrifos:
Analysis of Biomonitoring Data.'' The EPA encourages all grass-roots
organizations and residents to submit public comments on this issue
that is being addressed during the FIFRA Scientific Advisory Panel
meeting. The Agency also encourages community environmental justice
advocates to give a voice to their communities by nominating candidates
for consideration to serve on this panel.] Nominees should be
scientists who have sufficient professional qualifications, including
training and experience, to provide expert comments on the scientific
issues for this meeting. Nominees should be identified by name,
occupation, position, address, email address, and telephone number.
Nominations should be provided to the DFO listed under FOR FURTHER
INFORMATION CONTACT on or before March 23, 2016. The Agency will
consider all nominations of prospective candidates for this meeting
that are received on or before that date. However, final selection of
ad hoc members for this meeting is a discretionary function of the
Agency.
The selection of scientists to serve on FIFRA SAP is based on the
function of the Panel and the expertise needed to address the Agency's
charge to the Panel. No interested scientists shall be ineligible to
serve by reason of their membership on any other advisory committee to
a Federal department or agency, or their employment by a Federal
department or agency except EPA. Other factors considered during the
selection process include availability of the potential Panel member to
fully participate in the Panel's reviews, absence of any conflicts of
interest or appearance of lack of impartiality, independence with
respect to the matters under review, and lack of bias. Although
financial conflicts of interest, the appearance of lack of
impartiality, lack of independence, and bias may result in
disqualification, the
[[Page 12101]]
absence of such concerns does not assure that a candidate will be
selected to serve on the FIFRA SAP. Numerous qualified candidates are
identified for each Panel. Therefore, selection decisions involve
carefully weighing a number of factors including the candidates' areas
of expertise and professional qualifications and achieving an overall
balance of different scientific perspectives on the Panel. The Agency
anticipates selecting approximately 8 ad hoc scientists to have the
collective breadth of experience needed to address the Agency's charge
for this meeting.
FIFRA SAP members are subject to the provisions of 5 CFR part
2634--Executive Branch Financial Disclosure, Qualified Trusts, and
Certificates of Divestiture, as supplemented by EPA in 5 CFR part 6401.
In anticipation of this requirement, prospective candidates for service
on FIFRA SAP will be asked to submit confidential financial information
which shall fully disclose, among other financial interests, the
candidate's employment, stocks, and bonds, and where applicable,
sources of research support. EPA will evaluate the candidates'
financial disclosure form to assess whether there are financial
conflicts of interest, appearance of a lack of impartiality, or any
prior involvement with the development of the documents under
consideration (including previous scientific peer review) before the
candidate is considered further for service on the FIFRA SAP. Those who
are selected from the pool of prospective candidates will be asked to
attend the public meetings and to participate in the discussion of key
issues and assumptions at these meetings. In addition, they will be
asked to review and to help finalize the meeting minutes. The list of
FIFRA SAP members participating at this meeting will be posted on the
FIFRA SAP Web site at http://www.epa.gov/scipoly/sap or may be obtained
from the OPP Docket at http://www.regulations.gov.
II. Background
A. Purpose of FIFRA SAP
FIFRA SAP serves as the primary scientific peer review mechanism of
EPA's Office of Chemical Safety and Pollution Prevention (OCSPP) and is
structured to provide scientific advice, information and
recommendations to the EPA Administrator on pesticides and pesticide-
related issues as to the impact of regulatory actions on health and the
environment. FIFRA SAP is a Federal advisory committee established in
1975 under FIFRA that operates in accordance with requirements of the
Federal Advisory Committee Act (5 U.S.C. Appendix). FIFRA SAP is
composed of a permanent panel consisting of seven members who are
appointed by the EPA Administrator from nominees provided by the
National Institutes of Health and the National Science Foundation.
FIFRA established a Science Review Board (SRB) consisting of at least
60 scientists who are available to the FIFRA SAP on an ad hoc basis to
assist in reviews conducted by FIFRA SAP. As a scientific peer review
mechanism, FIFRA SAP provides comments, evaluations and recommendations
to improve the effectiveness and quality of analyses made by Agency
scientists. Members of the FIFRA SAP are scientists who have sufficient
professional qualifications, including training and experience, to
provide expert advice and recommendation to the Agency.
B. Public Meeting
Chlorpyrifos (0,0-diethyl-0-3,5,6-trichloro-2-pyridyl
phosphorothioate) is a broad-spectrum, chlorinated organophosphate (OP)
insecticide. The FIFRA SAP previously reviewed the human health effects
of chlorpyrifos in 2008 and 2012, and the chlorpyrifos physiologically-
based pharmacokinetic/pharmacodynamic (PBPK/PD) model in 2011. At the
2008 and 2012 SAP meetings, the Agency presented information on a
variety of science issues such as inhibition of the enzyme
acetylcholinesterase (AChE) in the nervous system, epidemiology studies
in infants and children which suggest that chlorpyrifos and other OPs
impact neurodevelopment, and a growing body of literature with
laboratory animals (rats and mice) indicating that gestational and/or
early postnatal exposure to chlorpyrifos may cause persistent effects
into adulthood. Like other OPs, chlorpyrifos binds to and
phosphorylates the enzyme acetylcholinesterase (AChE) in both the
central (brain) and peripheral nervous systems. This can lead to
accumulation of acetylcholine and ultimately, at sufficiently high
doses, to clinical signs of toxicity. As recommended by the FIFRA SAP
in 2008 and 2012, the Agency used inhibition of AChE as the critical
effect to derive points of departure for the 2014 human health risk
assessment. However, the 2014 human health risk assessment identified
uncertainty in the degree to which points of departure derived from
AChE inhibition are protective for neurodevelopmental effects in
humans.
In 2008 and 2012, the FIFRA SAP cautioned the Agency against using
the biomonitoring data from epidemiology studies, particularly those
from Columbia University in this case, to directly derive points of
departure due to uncertainties associated with a lack of knowledge
about timing of indoor chlorpyrifos applications and a single measure
of exposure (cord blood) which were collected by the Columbia
researchers. The concern is that single measures of exposure may not
reflect the entire pregnancy or temporal exposure uncertainty coupled
with unknown windows of susceptibility. The 2012 SAP recommended that
the Agency consider use of a PBPK model to further characterize the
dose estimates in the epidemiology studies. Based on human health risks
identified in the 2014 human health risk assessment, the Agency
published a 2015 proposed tolerance revocation for chlorpyrifos; in
that proposal the Agency noted that the evaluation of the available
biomonitoring was continuing. While EPA would have preferred to
complete that analysis prior to commencing rulemaking, the timing for
the proposal was directed by the U.S. Court of Appeals for the 9th
Circuit, which ordered EPA to respond to an administrative petition to
revoke all chlorpyrifos tolerances by October 31, 2015. In any case, at
this point in time, the Agency's analysis of biomonitoring data from
cord blood collected as part of the Columbia University epidemiology
studies has progressed to a point where peer review would be useful.
Specifically, the Agency has done additional characterization of the
pharmacokinetic profile of simulated exposures from oral and dermal
exposures using the PBPK model. Based on this evaluation, the Agency
now believes the cord blood data are sufficiently robust for deriving
points of departure. The Agency will solicit comment from the SAP on
the evaluation of biomonitoring data using the PBPK model, proposed
points of departure and extrapolation/uncertainty factors, and examples
of a proposed approach to use the PBPK model to simulate internal doses
from current exposure patterns from drinking water, food and worker
exposure.
C. FIFRA SAP Documents and Meeting Minutes
EPA's background paper, related supporting materials, charge/
questions to FIFRA SAP, FIFRA SAP composition (i.e., members and ad hoc
members for this meeting), and the meeting agenda will be available by
approximately mid-March. In addition, the Agency may provide additional
background documents as the materials become
[[Page 12102]]
available. You may obtain electronic copies of these documents and
certain other related documents that might be available at http://www.regulations.gov and the FIFRA SAP Web site at http://www.epa.gov/scipoly/sap.
FIFRA SAP will prepare meeting minutes summarizing its
recommendations to the Agency approximately 90 days after the meeting.
The meeting minutes will be posted to the FIFRA SAP Web site or may be
obtained from the OPP Docket at http://www.regulations.gov.
Authority: 7 U.S.C. 136 et seq.; 21 U.S.C. 301 et seq.
Dated: February 26, 2016.
David J. Dix,
Director, Office of Science Coordination and Policy.
[FR Doc. 2016-05174 Filed 3-7-16; 8:45 am]
BILLING CODE 6560-50-P